Additional file 1: Table S1. of Factors affecting survival after concurrent chemoradiation therapy for advanced hepatocellular carcinoma: a retrospective study

Additional file 1: of Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis

Carla Rognoni (3629486)
Oriana Ciani (4485976)
Silvia Sommariva (3564599)
Irene Bargellini (5486687)
Sherrie Bhoori (4537555)
Roberto Cioni (5486681)
Antonio Facciorusso (3594857)
Rita Golfieri (5486672)
Annagiulia Gramenzi (5486684)
Vincenzo Mazzaferro (216394)
Cristina Mosconi (5486678)
Francesca Ponziani (5486675)
Rodolfo Sacco (2626753)
Franco Trevisani (2626711)
Rosanna Tarricone (3629489)

July 2018

Table S1. Characteristics of unmatched and matched treatment groups; The table shows the characteris...

Additional file 2: of Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis

Shuling Chen (621838)
Zhenwei Peng (389483)
Mengchao Wei (5069009)
Weifeng Liu (635311)
Zihao Dai (5069006)
Haibo Wang (130324)
Jie Mei (153449)
Mingfong Cheong (5069015)
Hanmei Zhang (5069012)
Ming Kuang (1522798)

April 2018

Table S1. References used to derive monthly mortality of advanced HCC patients with compensated cirr...

Additional file 2: of Prognostic value of CC-chemokine receptor seven expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor

Yu Xia (8822)
Li Liu (75607)
Ying Xiong (245379)
Qi Bai (1518265)
Jiajun Wang (512021)
Wei Xi (3690508)
Yang Qu (681035)
Jiejie Xu (389064)
Jianming Guo (279212)

January 2017

Table S1.Univariate analyses of characteristics associated with overall survival and progression fre...

Additional file 1: of Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma

Wei Liu (20030)
Kun Wang (134525)
Quan Bao (3435044)
Yi Sun (118759)
Bao-Cai Xing (3435041)

March 2016

Figure S1. Kaplan-Meier curve showing overall survival of clinical risk factors. The more risk facto...

Additional file 1 of Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patients

Kong-Ying Lin (17585580)
Qing-Jing Chen (17585583)
Shi-Chuan Tang (17585586)
Zhi-Wen Lin (17585589)
Jian-Xi Zhang (17585592)
Si-Ming Zheng (17585595)
Yun-Tong Li (9093182)
Xian-Ming Wang (17585598)
Qiang Lu (49688)
Jun Fu (163683)
Luo-Bin Guo (17585601)
Li-Fang Zheng (2381464)
Peng-Hui You (17585604)
Meng-Meng Wu (4285399)
Ke-Can Lin (17585607)
Wei-Ping Zhou (123042)
Tian Yang (318007)
Yong-Yi Zeng (11555521)

December 2023

Supplementary Material 1: Table S1. Baseline characteristics of patients with different baseline AFP...

Additional file 1: Table S1. of A retrospective paired study: efficacy and toxicity of nimotuzumab versus cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma

H. Li (1597072)
P. Li (1413397)
Y. Qian (3540845)
X. Wu (681190)
L. Xie (3540848)
F. Wang (1690585)
H. Zhang (537656)
L. Liu (95204)

December 2016

Prognostic factors for overall survival (Univariate) (N = 104). Table S2. Prognostic factors for ove...

Additional file 2: of Cx32 exerts anti-apoptotic and pro-tumor effects via the epidermal growth factor receptor pathway in hepatocellular carcinoma

Yuke Xiang (6557186)
Qin Wang (109812)
Yunquan Guo (6557189)
Hui Ge (42549)
Yile Fu (6557195)
Xiyan Wang (457117)
Liang Tao (248968)

April 2019

Table S1. Cx32, Cx26 and Cx43 expression detected by immunohistochemical analysis in remote normal l...

Additional file 1: of Real life patterns of care and progression free survival in metastatic renal cell carcinoma patients: retrospective analysis of cross-sectional data

Rana Maroun (3129459)
Laura Mitrofan (4873909)
Laure Benjamin (2628880)
Gaelle Nachbaur (4279966)
Franck Maunoury (757097)
Philippe Le Jeunne (4873912)
Isabelle Durand-Zaleski (132356)

February 2018

Figure S1. Flow chart of included patients. Table S2. Table resuming patients âcharacteristics. Ta...

Additional file 3: of Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma

Jongmoo Park (5901848)
Jinhong Jung (2588161)
Daegeun Kim (5901851)
In-Hye Jung (5901854)
Jin-hong Park (481496)
Jong Kim (234077)
Sang-wook Lee (3358886)
Sang Yoon (3640075)

October 2018

Table S1. Factors associated with the local tumor control after hypofractionated radiotherapy. (DOCX...

Additional file 1: Table S1. of A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer

Gregory Vlacich (3638113)
Mark Stavas (3638122)
Praveen Pendyala (3638116)
Shaeu-Chiann Chen (3638125)
Yu Shyr (28592)
Anthony Cmelak (3638119)

January 2017

Chemotherapies Utilized in Sequential Boost Cohort. Table S2. Acute toxicity in sequential and integ...

Additional file 1: of Case series of cancer patients who developed cholecystitis related to immune checkpoint inhibitor treatment

Hamzah Abu-Sbeih (5791622)
Cynthia Tran (6664919)
Phillip Ge (6664922)
Manoop Bhutani (6664925)
Mazen Alasadi (6664928)
Aung Naing (160702)
Amir Jazaeri (6309530)
Yinghong Wang (174927)

May 2019

Table S1. Characteristics of patients by typicality of cholecystitis symptoms. Table S2. Characteris...

Additional file 2: of Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis

Chang Bang (3427028)
Il Song (3904897)

April 2017

Contains 6 tables including detailed meta-regression data of 6 study topics of this study. (DOC 79Â ...

Additional file 8: of First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers

Ying Fan (187798)
Shu Li (136154)
Xiaoyan Ding (291429)
Jian Yue (3159588)
Jun Jiang (149215)
Hong Zhao (325)
Rui Hao (9775)
Weiliang Qiu (74151)
Kezhen Liu (6526058)
Ying Li (38224)
Shengdian Wang (228349)
Limin Zheng (385489)
Bin Ye (686390)
Kun Meng (141278)
Binghe Xu (398866)

March 2019

Table S2. Baseline Characteristics and survival of HCC Patients (Comparison with the Chinese patient...

Additional file 1: of Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma

Jongmoo Park (5901848)
Jinhong Jung (2588161)
Daegeun Kim (5901851)
In-Hye Jung (5901854)
Jin-hong Park (481496)
Jong Kim (234077)
Sang-wook Lee (3358886)
Sang Yoon (3640075)

October 2018

Raw data of the patients. Patient characteristics and follow-up data exists. (XLSX 16Â kb

Additional file 3: of Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma

Wei Liu (20030)
Kun Wang (134525)
Quan Bao (3435044)
Yi Sun (118759)
Bao-Cai Xing (3435041)

March 2016

Figure S2. Kaplan-Meier Curve showing DFS of surgery plus TACE and surgery alone. (ZIP 396 KB

Additional file 1: of Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis

Carla Rognoni (3629486)
Oriana Ciani (4485976)
Silvia Sommariva (3564599)
Irene Bargellini (5486687)
Sherrie Bhoori (4537555)
Roberto Cioni (5486681)
Antonio Facciorusso (3594857)
Rita Golfieri (5486672)
Annagiulia Gramenzi (5486684)
Vincenzo Mazzaferro (216394)
Cristina Mosconi (5486678)
Francesca Ponziani (5486675)
Rodolfo Sacco (2626753)
Franco Trevisani (2626711)
Rosanna Tarricone (3629489)

July 2018

Table S1. Characteristics of unmatched and matched treatment groups; The table shows the characteris...

Additional file 2: of Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis

Shuling Chen (621838)
Zhenwei Peng (389483)
Mengchao Wei (5069009)
Weifeng Liu (635311)
Zihao Dai (5069006)
Haibo Wang (130324)
Jie Mei (153449)
Mingfong Cheong (5069015)
Hanmei Zhang (5069012)
Ming Kuang (1522798)

April 2018

Table S1. References used to derive monthly mortality of advanced HCC patients with compensated cirr...

Additional file 2: of Prognostic value of CC-chemokine receptor seven expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor

Yu Xia (8822)
Li Liu (75607)
Ying Xiong (245379)
Qi Bai (1518265)
Jiajun Wang (512021)
Wei Xi (3690508)
Yang Qu (681035)
Jiejie Xu (389064)
Jianming Guo (279212)

January 2017

Table S1.Univariate analyses of characteristics associated with overall survival and progression fre...

Additional file 1: of Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma

Wei Liu (20030)
Kun Wang (134525)
Quan Bao (3435044)
Yi Sun (118759)
Bao-Cai Xing (3435041)

March 2016

Figure S1. Kaplan-Meier curve showing overall survival of clinical risk factors. The more risk facto...

Additional file 1 of Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patients

Kong-Ying Lin (17585580)
Qing-Jing Chen (17585583)
Shi-Chuan Tang (17585586)
Zhi-Wen Lin (17585589)
Jian-Xi Zhang (17585592)
Si-Ming Zheng (17585595)
Yun-Tong Li (9093182)
Xian-Ming Wang (17585598)
Qiang Lu (49688)
Jun Fu (163683)
Luo-Bin Guo (17585601)
Li-Fang Zheng (2381464)
Peng-Hui You (17585604)
Meng-Meng Wu (4285399)
Ke-Can Lin (17585607)
Wei-Ping Zhou (123042)
Tian Yang (318007)
Yong-Yi Zeng (11555521)

December 2023

Supplementary Material 1: Table S1. Baseline characteristics of patients with different baseline AFP...

Additional file 1: Table S1. of A retrospective paired study: efficacy and toxicity of nimotuzumab versus cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma

H. Li (1597072)
P. Li (1413397)
Y. Qian (3540845)
X. Wu (681190)
L. Xie (3540848)
F. Wang (1690585)
H. Zhang (537656)
L. Liu (95204)

December 2016

Prognostic factors for overall survival (Univariate) (N = 104). Table S2. Prognostic factors for ove...

Additional file 2: of Cx32 exerts anti-apoptotic and pro-tumor effects via the epidermal growth factor receptor pathway in hepatocellular carcinoma

Yuke Xiang (6557186)
Qin Wang (109812)
Yunquan Guo (6557189)
Hui Ge (42549)
Yile Fu (6557195)
Xiyan Wang (457117)
Liang Tao (248968)

April 2019

Table S1. Cx32, Cx26 and Cx43 expression detected by immunohistochemical analysis in remote normal l...

Additional file 1: of Real life patterns of care and progression free survival in metastatic renal cell carcinoma patients: retrospective analysis of cross-sectional data

Rana Maroun (3129459)
Laura Mitrofan (4873909)
Laure Benjamin (2628880)
Gaelle Nachbaur (4279966)
Franck Maunoury (757097)
Philippe Le Jeunne (4873912)
Isabelle Durand-Zaleski (132356)

February 2018

Figure S1. Flow chart of included patients. Table S2. Table resuming patients âcharacteristics. Ta...

Additional file 3: of Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma

Jongmoo Park (5901848)
Jinhong Jung (2588161)
Daegeun Kim (5901851)
In-Hye Jung (5901854)
Jin-hong Park (481496)
Jong Kim (234077)
Sang-wook Lee (3358886)
Sang Yoon (3640075)

October 2018

Table S1. Factors associated with the local tumor control after hypofractionated radiotherapy. (DOCX...

Additional file 1: Table S1. of A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer

Gregory Vlacich (3638113)
Mark Stavas (3638122)
Praveen Pendyala (3638116)
Shaeu-Chiann Chen (3638125)
Yu Shyr (28592)
Anthony Cmelak (3638119)

January 2017

Chemotherapies Utilized in Sequential Boost Cohort. Table S2. Acute toxicity in sequential and integ...

Additional file 1: of Case series of cancer patients who developed cholecystitis related to immune checkpoint inhibitor treatment

Hamzah Abu-Sbeih (5791622)
Cynthia Tran (6664919)
Phillip Ge (6664922)
Manoop Bhutani (6664925)
Mazen Alasadi (6664928)
Aung Naing (160702)
Amir Jazaeri (6309530)
Yinghong Wang (174927)

May 2019

Table S1. Characteristics of patients by typicality of cholecystitis symptoms. Table S2. Characteris...

Additional file 2: of Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis

Chang Bang (3427028)
Il Song (3904897)

April 2017

Contains 6 tables including detailed meta-regression data of 6 study topics of this study. (DOC 79Â ...

Additional file 8: of First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers

Ying Fan (187798)
Shu Li (136154)
Xiaoyan Ding (291429)
Jian Yue (3159588)
Jun Jiang (149215)
Hong Zhao (325)
Rui Hao (9775)
Weiliang Qiu (74151)
Kezhen Liu (6526058)
Ying Li (38224)
Shengdian Wang (228349)
Limin Zheng (385489)
Bin Ye (686390)
Kun Meng (141278)
Binghe Xu (398866)

March 2019

Table S2. Baseline Characteristics and survival of HCC Patients (Comparison with the Chinese patient...

Additional file 1: of Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma

Jongmoo Park (5901848)
Jinhong Jung (2588161)
Daegeun Kim (5901851)
In-Hye Jung (5901854)
Jin-hong Park (481496)
Jong Kim (234077)
Sang-wook Lee (3358886)
Sang Yoon (3640075)

October 2018

Raw data of the patients. Patient characteristics and follow-up data exists. (XLSX 16Â kb

Additional file 3: of Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma

Wei Liu (20030)
Kun Wang (134525)
Quan Bao (3435044)
Yi Sun (118759)
Bao-Cai Xing (3435041)

March 2016

Figure S2. Kaplan-Meier Curve showing DFS of surgery plus TACE and surgery alone. (ZIP 396 KB

Additional file 1: of Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis

Carla Rognoni (3629486)
Oriana Ciani (4485976)
Silvia Sommariva (3564599)
Irene Bargellini (5486687)
Sherrie Bhoori (4537555)
Roberto Cioni (5486681)
Antonio Facciorusso (3594857)
Rita Golfieri (5486672)
Annagiulia Gramenzi (5486684)
Vincenzo Mazzaferro (216394)
Cristina Mosconi (5486678)
Francesca Ponziani (5486675)
Rodolfo Sacco (2626753)
Franco Trevisani (2626711)
Rosanna Tarricone (3629489)

July 2018

Table S1. Characteristics of unmatched and matched treatment groups; The table shows the characteris...

Additional file 2: of Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis

Shuling Chen (621838)
Zhenwei Peng (389483)
Mengchao Wei (5069009)
Weifeng Liu (635311)
Zihao Dai (5069006)
Haibo Wang (130324)
Jie Mei (153449)
Mingfong Cheong (5069015)
Hanmei Zhang (5069012)
Ming Kuang (1522798)

April 2018

Table S1. References used to derive monthly mortality of advanced HCC patients with compensated cirr...

Additional file 2: of Prognostic value of CC-chemokine receptor seven expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor

Yu Xia (8822)
Li Liu (75607)
Ying Xiong (245379)
Qi Bai (1518265)
Jiajun Wang (512021)
Wei Xi (3690508)
Yang Qu (681035)
Jiejie Xu (389064)
Jianming Guo (279212)

January 2017

Table S1.Univariate analyses of characteristics associated with overall survival and progression fre...

Additional file 1: Table S1. of Factors affecting survival after concurrent chemoradiation therapy for advanced hepatocellular carcinoma: a retrospective study

Abstract

Extracted data

Additional file 1: Table S1. of Factors affecting survival after concurrent chemoradiation therapy for advanced hepatocellular carcinoma: a retrospective study

Abstract

Extracted data

Related items

Related items